Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) — a meta-analysis

PURPOSE: To assess disease stability (absence of intra- and/or subretinal fluid) and the portion of eyes being capable to extend their treatment interval to ≥ 12 weeks in exudative age-related macular degeneration (AMD). METHODS: A systematic literature search was performed in NCBI, PubMed, CENTRAL,...

Descripción completa

Detalles Bibliográficos
Autores principales: Garweg, Justus G., Gerhardt, Christin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Retinal Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352813/
https://www.ncbi.nlm.nih.gov/pubmed/33528645
http://dx.doi.org/10.1007/s00417-020-05048-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352813/
https://www.ncbi.nlm.nih.gov/pubmed/33528645
http://dx.doi.org/10.1007/s00417-020-05048-1

Ejemplares similares